Results 21 to 30 of about 324 (51)

Cardiotoxic effects of pantoprazole in Wistar rats submitted to cardiac ischemia and reperfusion. [PDF]

Rev Assoc Med Bras (1992)
Santos ACD, Silva CMC, Araújo EA, Sassi LO, Caixeta A, Taha MO, Pires-Oliveira M, Caricati-Neto A, Lopes RD, Tallo FS, Menezes-Rodrigues FS.   +10 more
europepmc   +1 more source

Comparative analysis of the effect of PO administered acid suppressants on gastric pH in healthy cats. [PDF]

J Vet Intern Med, 2020
Ryan P, Odunayo A, Price J, Hecht S, Hillsman S, Galyon G, Steiner J, Tolbert MK.   +7 more
europepmc   +1 more source

14-day Empirical Therapy Compared with 7-day Tailored Therapy for <i>Helicobacter pylori</i> Eradication in Korea: Results of the K-CREATE Phase II Study. [PDF]

Yonsei Med J
Kim JS, Kim BW, Chung WC, Jung SW, Kim JI, Kim GH, Park SY, Jeon SW, Joo MK, Kim TH, Choi CW.   +10 more
europepmc   +1 more source

Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay. [PDF]

Sci Rep
Priyadharshini A, Vijayakumar TM, Damodharan N, Vasanth KM, Elaiyaraja A.   +4 more
europepmc   +1 more source

A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations. [PDF]

Br J Clin Pharmacol, 2020
Blanco Dorado S, Maroñas Amigo O, Latorre-Pellicer A, Rodríguez Jato MT, López-Vizcaíno A, Gómez Márquez A, Bardán García B, Belles Medall D, Barbeito Castiñeiras G, Pérez Del Molino Bernal ML, Campos-Toimil M, Otero Espinar F, Blanco Hortas A, Zarra Ferro I, Carracedo Á, Lamas MJ, Fernández-Ferreiro A.   +16 more
europepmc   +1 more source

Different Doses of Ilaprazole for Dual Therapy Versus Bismuth-Quadruple Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial. [PDF]

Helicobacter
Han Q, Zu M, Du S, Guo Y, Zhu Y, Wang Y, Liu X, Guo H, Cheng Y, Ding S.   +9 more
europepmc   +1 more source

Proton pump inhibitors and risk for gastric cancer: Is it real? [PDF]

Turk J Gastroenterol, 2019
Akriviadis E, Liava C.
europepmc   +1 more source

<i>In vitro</i> anti-<i>Helicobacter pylori</i> activity of ilaprazole used alone and in combination with other components of quadruple therapy. [PDF]

Microbiol Spectr
Zhang Z, Yang L, Sun W, Hu X, Nie T, Sun L, Li C, Yang X, Lu X, Pang J, You X.   +10 more
europepmc   +1 more source

Improving CYP2C19 phenotyping using stereoselective omeprazole and 5-hydroxy-omeprazole metabolic ratios. [PDF]

Basic Clin Pharmacol Toxicol
Abouir K, Varesio E, Déglon J, Samer C, Daali Y.   +4 more
europepmc   +1 more source

Use of Proton Pump Inhibitors and risk of gastric cancer. [PDF]

Turk J Gastroenterol, 2018
Karakan T.
europepmc   +1 more source